Sinochips Diagnostics is helping communities and health systems safely navigate through this pandemic by leveraging our state-of-the-art CLIA lab to provide a rapid, accurate, and highly scalable solution to detect active COVID-19 infections

Women's Health and Sexually Transmitted Infections

Sinochips Diagnostics Women’s Health and STI portfolio provides accurate, reliable results–enabling clinicians and labs to elevate patient care in reproductive health.

BD MAX™ Vaginal Panel

Real-Time Polymerase Chain Reaction (RT-PCR)

The BD MAX™ Vaginal Panel performed on the BD MAX System is an automated qualitative in vitro diagnostic test for the direct detection of DNA targets from bacteria associated with bacterial vaginosis (qualitative results reported based on detection and quantitation of targeted organism markers), Candida species associated with vulvovaginal candidiasis, and Trichomonas vaginalis from vaginal swabs in patients who are symptomatic for vaginitis/vaginosis. The test utilizes real-time polymerase chain reaction (PCR) for the amplification of specific DNA targets and utilizes fluorogenic target-specific hybridization probes to detect and differentiate DNA from:

  • Bacterial vaginosis markers(Individual markers not reported)
      • Lactobacillus spp. (L. crispatus and L. jensenii)
      • Gardnerella vaginalis
      • Atopobium vaginae
      • Bacterial Vaginosis Associated Bacteria-2 (BVAB-2)
      • Megasphaera-1
  • Candida (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis)
  • Candida glabrata
  • Candida krusei
  • Trichomonas vaginalis

BD MAX™ CT/GC/TV Panel

Real-Time Polymerase Chain Reaction (RT-PCR)

The BD MAX™ CT/GC/TV assay, as performed using the BD MAX System, incorporates automated DNA extraction and real-time polymerase chain reaction (PCR) for the direct, qualitative detection of DNA from Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC) and/or Trichomonas vaginalis (TV). The assay may be used for detection of CT and/or GC DNA in male urine specimens, and the detection of CT, GC and/or TV DNA in female urine specimens, clinician-collected female endocervical swab specimens and patient-collected vaginal swab specimens (in a clinical setting). The assay is indicated for use to aid in the diagnosis of chlamydial urogenital disease, gonococcal urogenital disease and/or trichomoniasis in asymptomatic and symptomatic individuals.

covid-19 test 72 hour turnaround time

Service Highlights

  • FDA-cleared IVD assays
  • Results available 3 days after sample receipt at Sinochips Diagnostics Laboratory
  • Results directly to ordering HCP using automated LIMS

Partnering with Sinochips Diagnostics Is Easy

Partnering with Sinochips Diagnostics Is Easy

1. Contact us

Contact Sinochips Diagnostics (877) 746-6244. Within 1 business day an account will be created, and you will receive access to our result portal.

2. Receive sample collection kits

Within 1-2 days the healthcare provider (HCP) will receive the sample collection kit for the Diagnostic (rRT-PCR) Test. The sample collection kit includes a nasopharyngeal swab and the universal transport media in a vial to maintain the RNA/DNA quality during transportation.

3. Send samples to us

After the test is ordered by the HCP and patient sample is collected, the HCP will put the sample, and the test order/requisition form in the provided bag and deliver to Sinochips Diagnostics

4. Receive results

The HCP will receive the results through our result portal within 1 business day for the Diagnostic (rRT-PCR) Test and Screening Test, and 3 business days for the Serology (Antibody) Test.